Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects

NCT04843449 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ASC40
DRUG: Itraconazole
DRUG: rifampicin

Sponsor

Ascletis Pharmaceuticals Co., Ltd.